Allianz Asset Management GmbH purchased a new stake in shares of Select Medical Holdings Co. (NYSE:SEM) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 44,090 shares of the health services provider’s stock, valued at approximately $847,000.
Several other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Select Medical by 3.9% in the second quarter. Vanguard Group Inc. now owns 9,929,821 shares of the health services provider’s stock worth $152,423,000 after acquiring an additional 369,044 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Select Medical by 1.8% in the third quarter. Dimensional Fund Advisors LP now owns 8,289,370 shares of the health services provider’s stock worth $159,154,000 after buying an additional 146,892 shares in the last quarter. Northern Trust Corp lifted its stake in shares of Select Medical by 14.6% in the second quarter. Northern Trust Corp now owns 2,325,289 shares of the health services provider’s stock worth $35,694,000 after buying an additional 296,087 shares in the last quarter. Voya Investment Management LLC lifted its stake in shares of Select Medical by 24.5% in the second quarter. Voya Investment Management LLC now owns 1,850,668 shares of the health services provider’s stock worth $28,407,000 after buying an additional 364,721 shares in the last quarter. Finally, Hood River Capital Management LLC purchased a new position in shares of Select Medical in the third quarter worth about $19,840,000. Hedge funds and other institutional investors own 77.89% of the company’s stock.
In related news, insider Michael E. Tarvin sold 18,500 shares of the business’s stock in a transaction dated Monday, October 30th. The shares were sold at an average price of $18.97, for a total value of $350,945.00. Following the sale, the insider now directly owns 340,044 shares in the company, valued at approximately $6,450,634.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Scott A. Romberger sold 5,000 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total transaction of $89,850.00. Following the completion of the transaction, the insider now owns 168,211 shares in the company, valued at $3,022,751.67. The disclosure for this sale can be found here. Insiders sold a total of 314,455 shares of company stock worth $5,403,144 over the last three months. 19.93% of the stock is currently owned by corporate insiders.
Shares of Select Medical Holdings Co. (NYSE:SEM) opened at $18.00 on Friday. The firm has a market cap of $2,380.00, a P/E ratio of 25.00, a PEG ratio of 1.18 and a beta of 1.34. Select Medical Holdings Co. has a 12-month low of $12.00 and a 12-month high of $19.77. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 3.36.
Select Medical (NYSE:SEM) last announced its earnings results on Thursday, November 2nd. The health services provider reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). The business had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.10 billion. Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The business’s revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.06 earnings per share. research analysts expect that Select Medical Holdings Co. will post 0.86 earnings per share for the current fiscal year.
Several equities analysts have recently weighed in on the stock. Zacks Investment Research raised shares of Select Medical from a “sell” rating to a “hold” rating in a research note on Saturday, January 6th. Robert W. Baird restated a “buy” rating and set a $21.00 price objective on shares of Select Medical in a research report on Tuesday, October 17th. ValuEngine upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Bank of America upgraded shares of Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 price target for the company in a research report on Thursday, January 4th. Finally, Royal Bank of Canada reissued a “buy” rating and issued a $19.00 price objective on shares of Select Medical in a research note on Friday, October 13th. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. Select Medical has a consensus rating of “Hold” and a consensus price target of $19.43.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://ledgergazette.com/2018/01/13/allianz-asset-management-gmbh-invests-847000-in-select-medical-holdings-co-sem.html.
Select Medical Profile
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.